107 related articles for article (PubMed ID: 34529585)
1. The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.
Rezamand G; Mahmoudi T; Tabaeian SP; Farahani H; Shahinmehr F; Nobakht H; Dabiri R; Asadi A; Mansour-Ghanaei F; Zali MR
Physiol Int; 2021 Sep; 108(3):342-352. PubMed ID: 34529585
[TBL] [Abstract][Full Text] [Related]
2. The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease.
Tabaeian SP; Mahmoudi T; Sabzikarian M; Rezamand G; Dabiri R; Nobakht H; Asadi A; Farahani H; Mansour-Ghanaei F; Zali MR
J Gastrointestin Liver Dis; 2021 Jun; 30(2):233-239. PubMed ID: 34174062
[TBL] [Abstract][Full Text] [Related]
3. Resistin -420C>G promoter variant and colorectal cancer risk.
Mahmoudi T; Karimi K; Arkani M; Farahani H; Vahedi M; Dabiri R; Nobakht H; Asadi A; Mirakhorli M; Arshi B; Derakhshan A; Zali MR
Int J Biol Markers; 2014 Sep; 29(3):e233-8. PubMed ID: 24585435
[TBL] [Abstract][Full Text] [Related]
4. Is really endogenous ghrelin a hunger signal in chickens? Association of GHSR SNPs with increase appetite, growth traits, expression and serum level of GHRL, and GH.
El-Magd MA; Saleh AA; Abdel-Hamid TM; Saleh RM; Afifi MA
Gen Comp Endocrinol; 2016 Oct; 237():131-139. PubMed ID: 27591070
[TBL] [Abstract][Full Text] [Related]
5. SNPs-Panel Polymorphism Variations in
Merabet N; Ramoz N; Boulmaiz A; Bourefis A; Benabdelkrim M; Djeffal O; Moyse E; Tolle V; Berredjem H
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137497
[TBL] [Abstract][Full Text] [Related]
6. INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.
Nobakht H; Mahmoudi T; Sabzikarian M; Tabaeian SP; Rezamand G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Maleki I; Zali MR
Arq Gastroenterol; 2020; 57(2):203-208. PubMed ID: 33206859
[TBL] [Abstract][Full Text] [Related]
7. A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.
Dabiri R; Mahmoudi T; Sabzikarian M; Asadi A; Farahani H; Nobakht H; Maleki I; Mansour-Ghanaei F; Derakshshan F; Zali MR
Acta Gastroenterol Belg; 2020; 83(2):271-276. PubMed ID: 32603046
[TBL] [Abstract][Full Text] [Related]
8. Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.
Nobakht H; Mahmoudi T; Rezamand G; Tabaeian SP; Jeddi G; Asadi A; Farahani H; Dabiri R; Mansour-Ghanaei F; Kaboli SA; Derakhshan F; Zali MR
Lab Med; 2022 Sep; 53(5):504-508. PubMed ID: 35713614
[TBL] [Abstract][Full Text] [Related]
9. The common variant of rs6214 in insulin like growth factor 1 (
Sabzikarian M; Mahmoudi T; Tabaeian SP; Rezamand G; Asadi A; Farahani H; Nobakht H; Dabiri R; Mansour-Ghanaei F; Derakhshan F; Zali MR
Arch Physiol Biochem; 2023 Feb; 129(1):10-15. PubMed ID: 32654522
[TBL] [Abstract][Full Text] [Related]
10. Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population.
Rivera-León EA; Llamas-Covarrubias MA; Sánchez-Enríquez S; Martínez-López E; González-Hita M; Llamas-Covarrubias IM
BMC Endocr Disord; 2020 Jul; 20(1):109. PubMed ID: 32698854
[TBL] [Abstract][Full Text] [Related]
11. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
[TBL] [Abstract][Full Text] [Related]
12. RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK.
Tabaeian SP; Mahmoudi T; Rezamand G; Nobakht H; Dabiri R; Farahani H; Asadi A; Zali MR
Arq Gastroenterol; 2022; 59(4):483-487. PubMed ID: 36515343
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.
Mahmoudi T; Nouri S; Zarei F; Najafabadi ZN; Sanei M; Sayedsalehi S; Rezamand G; Asadi A; Dabiri R; Nobakht H; Farahani H; Tabaeian SP; Zali MR
Arch Endocrinol Metab; 2023 Nov; 68():e230017. PubMed ID: 37948568
[TBL] [Abstract][Full Text] [Related]
14. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.
Uygun A; Ozturk K; Demirci H; Oztuna A; Eren F; Kozan S; Yilmaz Y; Kurt O; Turker T; Vatansever S; Alper E; Unsal B
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):441-447. PubMed ID: 28253210
[TBL] [Abstract][Full Text] [Related]
15. Leu72Met and Other Intronic Polymorphisms in the GHRL and GHSR Genes Are Not Associated with Type 2 Diabetes Mellitus, Insulin Resistance, or Serum Ghrelin Levels in a Saudi Population.
Joatar FE; Al Qarni AA; Ali ME; Al Masaud A; Shire AM; Das N; Gumaa K; Giha HA
Endocrinol Metab (Seoul); 2017 Sep; 32(3):360-369. PubMed ID: 28956366
[TBL] [Abstract][Full Text] [Related]
16. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity.
Gueorguiev M; Lecoeur C; Meyre D; Benzinou M; Mein CA; Hinney A; Vatin V; Weill J; Heude B; Hebebrand J; Grossman AB; Korbonits M; Froguel P
Obesity (Silver Spring); 2009 Apr; 17(4):745-54. PubMed ID: 19165163
[TBL] [Abstract][Full Text] [Related]
17. Associations of polymorphisms in GHRL, GHSR, and IGF1R genes with feed efficiency in chickens.
Jin S; Chen S; Li H; Lu Y; Xu G; Yang N
Mol Biol Rep; 2014 Jun; 41(6):3973-9. PubMed ID: 24566683
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.
Nouri S; Mahmoudi T; Hojjati F; Najafabadi ZN; Shafiee R; Sayedsalehi S; Dehghanitafti A; Ardalani A; Kohansal K; Rezamand G; Asadi A; Nobakht H; Dabiri R; Farahani H; Tabaeian SP; Zali MR
Lab Med; 2024 Mar; 55(2):215-219. PubMed ID: 37481466
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
[TBL] [Abstract][Full Text] [Related]
20. [Interaction of polymorphisms of monocyte chemoattractant protein-1 receptor CCR2 gene 190A/G, nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene C242T and cigarette smoking increases the risk of nonalcoholic fatty liver disease].
Zhang C; Guo L
Wei Sheng Yan Jiu; 2015 Sep; 44(5):730-7. PubMed ID: 26591766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
